Publication:
Impact of preventive actions on rejection rates in the preanalytical period

dc.contributor.buuauthorOdabaşı, Merve Sena
dc.contributor.buuauthorDirican, Melahat
dc.contributor.buuauthorOral, Arzu Yılmaztepe
dc.contributor.buuauthorYILMAZTEPE ORAL, ARZU
dc.contributor.buuauthorÖzkaya, Guven
dc.contributor.buuauthorÖZKAYA, GÜVEN
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı.
dc.contributor.orcid0000-0003-3774-4241
dc.contributor.orcid0000-0002-8962-9758
dc.contributor.orcid0000-0003-0297-846X
dc.contributor.researcheridAAG-6985-2021
dc.contributor.researcheridA-5841-2017
dc.contributor.researcheridA-4421-2016
dc.date.accessioned2024-07-05T06:27:20Z
dc.date.available2024-07-05T06:27:20Z
dc.date.issued2020-02-01
dc.description.abstractBackground: It is responsibility of medical laboratories to determine and reject nonconforming samples as well as take preventive actions. In this study, we examined reasons and percentages of rejected samples. We also investigated impact of the preventive actions on decreasing the rejection rates.Materials and methods: Reasons for rejection were determined by Pareto analysis. Sigma analysis was used for each month to evaluate the ratios and compare with other studies. Some preventive actions were taken to reduce the rejection rates. Pearson's chi square test was used to evaluate effects of preventive actions. Significance level was determined as p <0.05.Results: Most of the rejected samples consisted of samples not received by the laboratory, haemolysed and insufficient samples. The percentages of samples not received by the laboratory and insufficient samples were reduced from 3.80% to 1.94% and 0.33% to 0.31% respectively, while haemolysed samples percentage was increased from 2.83% to 3.37% after the improvement actions. Also, sigma levels for samples not received by the laboratory and haemolysed samples were at the minimum while insufficient samples were at a reasonable level.Conclusion: Improvement actions achieved statistically significant decreases for samples not received by the laboratories for a long-term.
dc.identifier.doi10.1515/tjb-2018-0119
dc.identifier.endpage25
dc.identifier.issn0250-4685
dc.identifier.issue1
dc.identifier.startpage19
dc.identifier.urihttps://doi.org/10.1515/tjb-2018-0119
dc.identifier.urihttps://hdl.handle.net/11452/42945
dc.identifier.volume45
dc.identifier.wos000525736100003
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherWalter De Gruyter Gmbh
dc.relation.journalTurkish Journal Of Biochemistry-turk Biyokimya Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectQuality indicators
dc.subjectErrors
dc.subjectSigma level
dc.subjectPre-analytical error
dc.subjectRejection rates
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectBiochemistry & molecular biology
dc.titleImpact of preventive actions on rejection rates in the preanalytical period
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationbe5015fb-eb9a-40c7-b63c-ed6175c7d799
relation.isAuthorOfPublication648e85b9-2f4f-4f92-a2d7-794286abd0fd
relation.isAuthorOfPublication.latestForDiscoverybe5015fb-eb9a-40c7-b63c-ed6175c7d799

Files

Collections